Oxygenta [OXYGENTAPH] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Oxygenta

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oxygenta wins in 7 metrics, Divi's Laboratories wins in 11 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricOxygentaDivi's LaboratoriesBetter
P/E Ratio (TTM)444.3267.57Divi's Laboratories
Price-to-Book Ratio-10.3110.40Oxygenta
Debt-to-Equity Ratio-2.490.03Oxygenta
PEG Ratio1.382.55Oxygenta
EV/EBITDA-24.1949.66Oxygenta
Profit Margin (TTM)-13.45%23.89%Divi's Laboratories
Operating Margin (TTM)-50.72%25.60%Divi's Laboratories
EBITDA Margin (TTM)N/A25.60%N/A
Return on Equity38.69%14.64%Oxygenta
Return on Assets (TTM)-11.61%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-87.89M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-20.28%-5.14%Divi's Laboratories
Price-to-Sales Ratio (TTM)2.2216.13Oxygenta
Enterprise Value$3.17B$1,522.01BDivi's Laboratories
EV/Revenue Ratio2.8415.77Oxygenta
Gross Profit Margin (TTM)-24.33%60.33%Divi's Laboratories
Revenue per Share (TTM)$31$363Divi's Laboratories
Earnings per Share (Diluted)$-3.95$86.82Divi's Laboratories
Beta (Stock Volatility)0.420.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Oxygenta vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Oxygenta
Divi's Laboratories
Oxygenta Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta1.06%1.69%-4.31%-39.94%-9.48%-18.70%
Divi's Laboratories-0.67%2.26%-3.33%-15.42%10.79%-4.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta-20.28%144.99%530.20%969.02%609.78%191.63%
Divi's Laboratories-5.14%63.08%80.80%444.71%1,530.25%8,023.95%

News Based Sentiment: Oxygenta vs Divi's Laboratories

Oxygenta

News based Sentiment: NEGATIVE

September brought concerning financial results for Oxygenta Pharmaceutical, with a substantial increase in net loss and a declining share price. While the AGM took place, the underlying financial challenges and mixed investor signals create a negative outlook for the month, making it a significant period for investors to reassess their positions.

View Oxygenta News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong Q3 results, but also faces mixed analyst opinions, recent underperformance, and a shift in technical trends. The company is also taking on new debt, indicating a strategic change. These factors create a complex investment narrative.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Oxygenta vs Divi's Laboratories

MetricOXYGENTAPHDIVISLAB
Market Information
Market Cap i₹2.61B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i6,823455,187
90 Day Avg. Volume i7,182395,686
Last Close₹69.70₹5,826.50
52 Week Range₹67.00 - ₹133.50₹4,955.00 - ₹7,071.50
% from 52W High-47.79%-17.61%
All-Time High₹133.50 (Jun 09, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-47.79%-17.61%
Growth Metrics
Quarterly Revenue Growth0.20%0.14%
Quarterly Earnings GrowthN/A0.27%
Financial Health
Profit Margin (TTM) i-0.13%0.24%
Operating Margin (TTM) i-0.51%0.26%
Return on Equity (TTM) i0.39%0.15%
Debt to Equity (MRQ) i-2.490.03
Cash & Liquidity
Book Value per Share (MRQ)₹-7.15₹563.87
Cash per Share (MRQ)₹0.03₹132.86
Operating Cash Flow (TTM) i₹-61,057,000₹19.67B
Levered Free Cash Flow (TTM) i₹-96,826,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Oxygenta vs Divi's Laboratories

MetricOXYGENTAPHDIVISLAB
Price Ratios
P/E Ratio (TTM) i444.3267.57
Forward P/E iN/A104.19
PEG Ratio i1.382.55
Price to Sales (TTM) i2.2216.13
Price to Book (MRQ) i-10.3110.40
Market Capitalization
Market Capitalization i₹2.61B₹1.61T
Enterprise Value i₹3.17B₹1.52T
Enterprise Value Metrics
Enterprise to Revenue i2.8415.77
Enterprise to EBITDA i-24.1949.66
Risk & Other Metrics
Beta i0.420.18
Book Value per Share (MRQ) i₹-7.15₹563.87

Financial Statements Comparison: Oxygenta vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)OXYGENTAPHDIVISLAB
Revenue/Sales i₹151.35M₹24.10B
Cost of Goods Sold i₹188.17M₹9.56B
Gross Profit i₹-36.83M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-76.77M₹6.17B
EBITDA i₹-66.61M₹8.48B
Pre-Tax Income i₹-81.48M₹7.33B
Income Tax i₹-20.42M₹1.88B
Net Income (Profit) i₹-61.06M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)OXYGENTAPHDIVISLAB
Cash & Equivalents i₹17,000₹4.15B
Total Current Assets i₹309.43M₹100.81B
Total Current Liabilities i₹858.47M₹14.52B
Long-Term Debt i₹215.22M₹20.00M
Total Shareholders Equity i₹-250.25M₹149.69B
Retained Earnings i₹-735.63M₹134.00B
Property, Plant & Equipment i₹14.36M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)OXYGENTAPHDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,823455,187
Average Daily Volume (90 Day) i7,182395,686
Shares Outstanding i36.98M265.47M
Float Shares i3.88M120.77M
% Held by Insiders i0.80%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Oxygenta vs Divi's Laboratories

MetricOXYGENTAPHDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025